Please login to the form below
open letter
This page shows the latest open letter news and features for those working in and with pharma, biotech and healthcare.
Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
In an open letter to Pfizer employees published last week, the company’s chief executive and chairman Albert Bourla said that “the proposed waiver for COVID-19 vaccines threatens to disrupt
Latest news
-
Pfizer, BioNTech file for full US approval of COVID-19 vaccine
In an open letter to Pfizer employees, Bourla also responded to the news that the US is supporting a proposal to waive intellectual property (IP) protections on COVID-19 vaccines.
-
Dear Joe
An open letter to the incoming President of the United States on COVID-19 messaging priorities.
-
NHS gearing up for possible pre-Christmas COVID-19 vaccinations
In an open letter published on 16 October, Pfizer’s chief executive officer Albert Bourla said that the company is hoping to submit its BioNTech-partnered COVID-19 vaccine candidate for
-
UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
Pfizer is expecting the first efficacy data from its phase 3 trial of BNT162b2, with chief executive officer Albert Bourla revealing in an open letter published last week that the company
-
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
However, in an open letter published last week, Bourla said that the companies will not submit the vaccine for emergency use authorisation in the US until the third week of November.
Pfizer, BioNTech file for full US approval of COVID-19 vaccine
Dear Joe
NHS gearing up for possible pre-Christmas COVID-19 vaccinations
UK Vaccine Taskforce chief says first COVID-19 vaccines ‘likely to be imperfect’
Pfizer CEO says COVID-19 vaccine efficacy data could come ‘soon’
More from news
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest from PMHub
-
Language barriers: Obesity has become a loaded word
shaming’. However, this didn’t just come from body positivity campaigners – academics and nutritionists from respected institutions also warned in an open letter that the campaign may make people with obesity
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Senior Account Director, Publications, Opthalmology, Medical Com...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Senior Medical Writer, Rare diseases, Medical Communications age...
-
Highly competitive salary
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Publications, Women’s health, Medical C...
-
Highly competitive salary
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Publications, Opthalmology, Medical Communicat...
-
Highly competitive salary
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Senior Account Manager
-
Salary TBC
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
- Positive late-stage results for Novartis’ radioligand therapy in advanced prostate cancer
- Court rules on AZ and EU’s COVID-19 vaccine dispute
- BMS and Eisai to collaborate in deal worth up to $3.1bn
- US announces $3bn funding boost for antiviral COVID-19 treatments
- Biogen doses first patient in phase 3 systemic lupus erythematosus study
- Kite partners with Shoreline Biosciences to develop allogeneic cell therapies
- ‘Funny’, ha ha: how neurodiverse comedy can help us understand each other
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- BeiGene’s reveals positive data for Brukinsa in head-to-head Imbruvica trial
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Packer Forbes acquired by Four Communications
- AI is transforming pharma R&D – now it can transform pharma marketing
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- How early-stage clinical research is facilitating the new wave of personalised medicines
- By Jorg Taubel...
- Patient diversity in clinical trials needs to be centre stage
- By Danny Buckland...
- Why empathy in digital patient recruitment is vital
- This is where empathy mapping can be incredibly effective....
